Otezla Is Amgen’s Main Growth Driver As Net Drug Pricing Declines

Financial Report
Otezla will boost Amgen's 2020 sales as net price declines hit other drugs • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business